Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small ...

Dr. Hussein Tawbi, who works for MD Anderson in Houston, said there are two things he hopes people take away from the story ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Onward Medical has received FDA approval to begin a pivotal study of its Arc-IM system, an implantable neurostimulation therapy designed to treat blood pressure instability after spinal cord injury, ...